Heartflow (NASDAQ:HTFL) CFO Sells 668 Shares of Stock

Heartflow, Inc. (NASDAQ:HTFL) CFO Vikram Verghese sold 668 shares of Heartflow stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $50.01, for a total transaction of $33,406.68. Following the transaction, the chief financial officer directly owned 179,528 shares in the company, valued at approximately $8,978,195.28. This trade represents a 0.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The stock was sold at an average price of $50.06, for a total value of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total transaction of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The shares were sold at an average price of $49.69, for a total value of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The shares were sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Down 2.4%

Shares of NASDAQ:HTFL traded down $1.21 during trading on Tuesday, reaching $48.33. The stock had a trading volume of 2,031,448 shares, compared to its average volume of 1,972,264. The stock has a fifty day simple moving average of $36.39 and a two-hundred day simple moving average of $31.21. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $51.78. The firm has a market capitalization of $4.20 billion and a price-to-earnings ratio of -26.41.

Heartflow (NASDAQ:HTFL) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The business had revenue of $64.08 million for the quarter. The business’s revenue was up 47.7% compared to the same quarter last year. On average, analysts forecast that Heartflow, Inc. will post -0.75 EPS for the current year.

More Heartflow News

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
• Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
• Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
• Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
• Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
• Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HTFL. Weiss Ratings upgraded shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. UBS Group initiated coverage on shares of Heartflow in a research note on Wednesday, September 9th. They issued a “neutral” rating and a $55.00 target price on the stock. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a report on Friday, August 14th. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. Finally, Robert W. Baird set a $45.00 price target on Heartflow in a research note on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $44.88.

Institutional Investors Weigh In On Heartflow

A number of hedge funds have recently added to or reduced their stakes in the company. Engineers Gate Manager LP acquired a new position in shares of Heartflow during the second quarter worth approximately $590,000. Integrated Wealth Concepts LLC bought a new stake in Heartflow during the 2nd quarter valued at $53,000. Squarepoint Ops LLC raised its holdings in Heartflow by 72.0% during the second quarter. Squarepoint Ops LLC now owns 87,052 shares of the company’s stock worth $2,554,000 after buying an additional 36,441 shares during the last quarter. Arizona State Retirement System bought a new position in shares of Heartflow in the second quarter valued at $312,000. Finally, Allianz Asset Management GmbH acquired a new position in shares of Heartflow during the second quarter valued at about $1,557,000.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries.

The company’s primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).